148 related articles for article (PubMed ID: 935083)
1. [Treatment of diabetes mellitus with long-acting biguanides].
Kliachko VR; Perelygina AA; Mazovetskiĭ AG; Slavina LS
Probl Endokrinol (Mosk); 1976; 22(3):22-6. PubMed ID: 935083
[TBL] [Abstract][Full Text] [Related]
2. [Second generation sulfonylurea preparations in the therapy of diabetes mellitus].
Kliachko VR; Perelygina AA; Mazovetskiĭ AG
Probl Endokrinol (Mosk); 1975; 21(5):3-6. PubMed ID: 132655
[TBL] [Abstract][Full Text] [Related]
3. [Simplified combination treatment of diabetes mellitus with sulfonylurea compounds and biguanides].
Bock E
Z Allgemeinmed; 1975 Jan; 51(1):37. PubMed ID: 1216880
[No Abstract] [Full Text] [Related]
4. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
Fövényi J
Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
[No Abstract] [Full Text] [Related]
5. [Clinical tests on Glucophage retard in 50 obese adult patients with adjusted diabetes mellitus].
Kopp H
Med Welt; 1974 Apr; 25(15):658-60. PubMed ID: 4825496
[No Abstract] [Full Text] [Related]
6. [The effect of biguanide preparations on lipid metabolism].
Pavlov K
Vutr Boles; 1974; 13(6):115-8. PubMed ID: 4467468
[TBL] [Abstract][Full Text] [Related]
7. Biguanide treatment in diabetes mellitus: a short review.
Clarke BF
Scott Med J; 1977 Apr; 22(2):167-70. PubMed ID: 860117
[No Abstract] [Full Text] [Related]
8. [Combined administration of insulin and oral agents].
Tasaka H
Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
[No Abstract] [Full Text] [Related]
9. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
Lunetta M; Presti C; Mughini MT; Mughini L
Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
[No Abstract] [Full Text] [Related]
10. [Combined administration of oral agents in insulin therapy].
Oneta A
Nihon Rinsho; 1973 Jul; 31(7):2293-7. PubMed ID: 4795330
[No Abstract] [Full Text] [Related]
11. [Treatment of patients with diabetes and diabetic angiopathies of the lower extremities with butylbiguanide (Silubin retard)].
Tikholov K
Ter Arkh; 1974; 46(1):111-3. PubMed ID: 4453970
[No Abstract] [Full Text] [Related]
12. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
13. Oral hypoglycemic agents.
Forbath N
Prim Care; 1977 Dec; 4(4):629-36. PubMed ID: 337336
[TBL] [Abstract][Full Text] [Related]
14. [Results in diabetic therapy with Silubin retard. 3].
Kopp H
Med Klin; 1971 Feb; 66(7):246-7. PubMed ID: 5552720
[No Abstract] [Full Text] [Related]
15. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
16. [Diabetes mellitus and obesity: monotherapy using biguanides].
Bäbler M
Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806
[No Abstract] [Full Text] [Related]
17. The treatment of diabetes mellitus with a retard form of butylbiguanide.
Mehnert H; Mahrhofer E; Stern G
Ger Med Mon; 1966 Jun; 11(6):224-7. PubMed ID: 5947771
[No Abstract] [Full Text] [Related]
18. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
Singer P; Thoelke H
Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
[No Abstract] [Full Text] [Related]
19. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
Mehnert H
Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
[No Abstract] [Full Text] [Related]
20. [Silubin retard--long-term effects].
Dub O; Brozek I; Pátek F
Cas Lek Cesk; 1971 Jun; 110(25):591-4. PubMed ID: 5088225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
